Takeda's Qdenga Becomes India's First Dengue Vaccine
India's drug regulator has approved Takeda's Qdenga as the country's first dengue vaccine, covering all four virus strains for people aged four to sixty. Commercial availability is expected in the first half of 2027, with Takeda partnering Biological E to expand manufacturing capacity.